Bgl I from Takara Mirus Bio
Navigation Links
Bgl I from Takara Mirus Bio
| Products | Bgl I from Takara Mirus Bio | |
| Company | Takara Mirus Bio | |
| Item | Bgl I | |
| Price | $23.00 | |
| Description | ||
| Info |  Takara Mirus Bio510 Charmany Drive Suite 273 Madison, WI 53719 USA
Fax Number: (608) 441-2845 Web Site: http://www.takaramirusbio.com |
1-866-536-4401NOTE: Price information is approximate list price and actual prices may vary.
Related biology products :
1. GPDH Assay Kit from Takara Mirus Bio
2. Mun I (Mfe I) from Takara Mirus Bio
3. BspT107 I (HgiC I, Ban I) from Takara Mirus Bio
4. Acc I from Takara Mirus Bio
5. Sma I (High Concentration) from Takara Mirus Bio
6. Hae III (High Concentration) from Takara Mirus Bio
7. Hae III from Takara Mirus Bio
8. Psp1406 I from Takara Mirus Bio
9. SPACED COVER GLASS S (22X24 MM) from Takara Mirus Bio
10. Kilo Sequencing Deletion Kit from Takara Mirus Bio
11. Cassette, Sal I from Takara Mirus Bio
Biology Products:
Mouse Anti-PRMT5 Monoclonal Antibody, Unconjugated, Clone PRMT5-21 from AbcamGoat Anti-Mouse TrkC Polyclonal Antibody, Unconjugated from R&D SystemsRat Anti-Mouse MMP-24 (MT5-MMP) Monoclonal Antibody, Unconjugated, Clone 143908 from R&D SystemsTMB Slow Kinetic One Component HRP Microwell Substrate from BioFX Laboratories, Inc.
Breaking Biology News(10 mins):Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 2Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 3Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 4More than fish bait: Worms unlock secrets to new epilepsy treatments 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 1Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 3Craneware Announces Fiscal Year End Results 56424 1Craneware Announces Fiscal Year End Results 56424 2Craneware Announces Fiscal Year End Results 56424 3Invision Sally Jobe Names Breast Network Medical Director 56421 1Invision Sally Jobe Names Breast Network Medical Director 56421 2
Other Biology News:MBL director and CEO and cell biology pioneer Gary Borisy elected to National Academy of Sciences 2MBL director and CEO and cell biology pioneer Gary Borisy elected to National Academy of Sciences 3Satellite imagery shows fragile Wilkins Ice Shelf destabilized 2Stem cell focus for IBD wound healing 2
Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4
[0] Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner [0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain[0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |